INTRODUCTION:

This research paper is geared towards assisting pharmaceutical companies in making well-informed decisions related to drug development, pricing, and marketing strategies. The primary goal is to delve into drug sales data, deciphering patterns and trends to offer valuable insights that can guide strategic decision-making. To conduct this research, we are employing a survey-based approach, gathering information from pharmaceutical companies, healthcare providers, and various stakeholders in the industry. This comprehensive methodology encompasses a broad spectrum of medications, including both prescription and over-the-counter drugs. We are examining overall sales trends, popular drug categories, and the specific performance of individual drugs.

Factors such as effectiveness, marketing strategies, pricing, and the dynamics of market demand are thoroughly investigated to gain a comprehensive understanding of the drivers influencing market demand. Identifying drugs with high market demand holds significant importance for pharmaceutical companies. It not only aids in streamlining research and development efforts towards high-growth areas but also increases the likelihood of a favorable return on investment. Furthermore, this knowledge facilitates the development of optimized pricing strategies that strike a balance between competitiveness and profitability. Additionally, awareness of drugs with high market demand allows companies to allocate their marketing resources judiciously, maximizing reach and impact. The anticipated outcomes of this research are expected to empower pharmaceutical companies in refining their strategic planning, optimizing pricing structures, and designing targeted marketing campaigns. These insights can significantly contribute to the pharmaceutical market landscape, providing valuable assistance to industry stakeholders in making astute decisions. Beyond the pharmaceutical industry, the implications of this research extend to healthcare providers, regulatory authorities, and policymakers. The knowledge derived from understanding market dynamics and identifying drugs in high demand can play a pivotal role in shaping decisions related to patient care, reimbursement policies, and healthcare regulations. In essence, this research seeks to underscore the integral role of analyzing drug sales data in steering informed decision-making and fostering improvements in global healthcare. The optimization of pricing strategies based on identified market demand is positioned as a linchpin for the sustainability and profitability of pharmaceutical ventures. The judicious allocation of marketing resources, guided by insights gleaned from the analysis, empowers companies to reach their target audiences effectively and maximize the impact of their promotional. The broader implications transcend the pharmaceutical industry, offering benefits to healthcare providers in making informed choices in patient care, while regulatory authorities and policymakers can leverage these insights to formulate effective healthcare regulations and reimbursement policies. The collaborative approach facilitated by the survey-based methodology encourages cooperation among pharmaceutical companies, healthcare providers, and other industry stakeholders. This collaborative environment fosters a collective understanding of market dynamics, creating a space where insights and best practices can be shared. The exchange of information holds the potential to generate synergies in research and development efforts, potentially accelerating the pace of medical advancements. By identifying drugs with high market demand, this research not only aids in resource optimization but also contributes to addressing public health needs more effectively. Pharmaceutical companies can align their efforts with prevailing health concerns, leading to the development of drugs that effectively address urgent medical challenges. The significance of analyzing drug sales data, therefore, extends beyond individual enterprises to serve as a valuable tool for all stakeholders, fostering informed decision-making and contributing to the overall enhancement of global healthcare^1,2,3,4

AIM:

The aim of this survey is to analyse drug sales data and identify drugs that demonstrate high and low market demand. By investigating the factors that contribute to the success of certain drugs in the market, this research aims to provide insights into the dynamics of drug sales and their implications for the pharmaceutical industry, healthcare providers, policymakers and investors.

OBJECTIVES:

To examine overall drug sales trends and patterns:

Analyzing the broader trends and patterns in pharmaceutical sales is crucial for gaining a comprehensive understanding of the market. This examination goes beyond just identifying growth rates; it also delves into seasonal variations and the dynamic nature of the market. Such insights are invaluable for strategic planning, resource allocation, and effectively responding to shifts in demand, providing a foundation for well-informed decision-making within the pharmaceutical sector.

Moreover, a meticulous exploration of drug sales trends offers stakeholders the ability to pinpoint successful products and comprehend consumer preferences. By recognizing patterns, companies can refine their marketing strategies, optimize inventory management, and proactively address fluctuations in demand. This not only contributes to maximizing profitability but also fosters the development of sustainable business practices within the pharmaceutical industry.

To identify top-selling drug categories:

The primary aim of this objective is to systematically classify drugs according to their therapeutic areas or indications, with a particular focus on identifying categories that consistently exhibit strong sales figures. This categorization approach holds significant importance as it provides a key foundation for comprehending market trends, streamlining resource allocation, and addressing healthcare needs more effectively.

By organizing drugs based on their therapeutic areas, we gain the ability to scrutinize sales data in a targeted manner. This, in turn, enables us to prioritize and direct research, development, and marketing efforts towards the therapeutic categories that exhibit consistent demand. Such a strategic focus not only optimizes resource utilization but also has the potential to enhance healthcare outcomes by ensuring that attention and resources are channeled into areas that align with market needs.

In essence, the systematic categorization of drugs based on therapeutic areas serves as a crucial tool for refining industry strategies. It facilitates a more nuanced understanding of market dynamics, allowing for informed decision-making that can ultimately lead to improvements in healthcare efficiency and outcomes.

This approach enables pharmaceutical companies to allocate resources strategically, invest in high-demand therapeutic areas, and tailor marketing strategies to specific medical needs.⁵

METHODS:

Define the research objectives:

This goal is all about sorting drugs based on what they're used for and finding out which types consistently sell well. This sorting method is important because it forms the basis for understanding how the market behaves, making it easier to manage resources and meet healthcare needs effectively. When we organize drugs by their purposes, we can look closely at sales data for each category. This helps us decide where to focus our efforts in research, development, and marketing – putting more attention on the types of drugs that people consistently want. This approach not only helps us use our resources wisely but also has the potential to make healthcare better by directing efforts toward areas that match what people need. In simple terms, sorting drugs systematically by their purposes is a vital tool for improving how the industry works. It helps us grasp the details of how the market behaves, making smart decisions that can lead to better healthcare efficiency and outcomes.

Sampling strategy:

Determine the target population for your survey. If your aim is to study drug sales in a specific geographic area, you might want to use a random or stratified sampling technique to ensure representative results. Alternatively, if you have access to specific data sources (e.g., drug enforcement agencies), you could use purposive sampling to select relevant individuals or organizations.

Choosing an appropriate sampling strategy is crucial. For instance, in studying drug sales in a specific area, random or stratified sampling ensures representative results across demographics. Purposive sampling, drawing from specific data sources like drug enforcement agencies, allows targeted selection for a more in-depth understanding of the issue. The strategy aligns with the research objectives, enhancing the survey’s overall reliability and relevance.

Consider factors such as sample size, ensuring it is statistically significant for meaningful results. Documenting the sampling process comprehensively enhances transparency and replicability. A well-defined sampling strategy contributes to the survey’s validity and the generalizability of findings to the broader population of interest.

Data collection:

Decide on the method of data collection that best suits your objectives and resources. Common methods include face-to-face interviews, telephone surveys, online surveys, or a combination of these. Each method has its pros and cons, so consider factors like cost, time, and the accessibility of the target population.

Selecting an appropriate data collection method is pivotal. Face-to-face interviews, telephone surveys, and online surveys offer varied advantages and drawbacks. Assess factors such as cost, time constraints, and accessibility of the target population when making this decision. Striking a balance between efficiency and accuracy aligns the data collection process with the overall research objectives, optimizing resource utilization for meaningful insights.

When implementing the chosen data collection method, ensure standardized protocols to maintain consistency and reliability across responses. Monitoring and addressing any potential biases introduced during data collection enhance the robustness of the survey outcomes. Regularly assess the progress and adapt strategies if needed to overcome unforeseen challenges during the data collection phase.

Pre-testing:

Before launching the full survey, conduct a pilot study or pre-test to evaluate the clarity, relevance, and effectiveness of the survey instrument. This can help identify any potential issues or areas for improvement.

It is crucial to evaluate the survey instrument’s effectiveness. A pilot study helps assess clarity, relevance, and potential issues, ensuring the refinement of the questionnaire before the full survey. This proactive approach enhances the reliability and validity of the data collected, improving the overall quality of insights gained from the survey.

During pre-testing, gather feedback from a small, diverse group to identify any ambiguous questions, confusing language, or response patterns. Addressing these issues before the full survey enhances the instrument’s reliability. Consider refining the survey based on pre-test insights, ensuring that the final version is well-suited to capture accurate and meaningful data from the target population. ^6,7,8

RESULT OBTAINED FROM SURVEY:

OBSERVATION:

From the survey of sales of drugs (Antibiotics) done in Navi Mumbai, observation are given below;

Amoxicillin is highlighted for its widespread use and popularity due to its effectiveness, safety record, and oral administration convenience. However, concerns about antibiotic resistance underscore the need for cautious prescribing practices.

Cefixime and Amoxicillin are compared, and their selection depends on factors like dosing frequency, patient adherence, and bacterial coverage. Both play significant roles in clinical practice, and monitoring antibiotic resistance is crucial for effective treatment.

Ciprofloxacin is commonly available but restricted in prescription due to potential side effects and antibiotic resistance concerns. Regulatory measures aim to ensure responsible use, emphasizing the importance of consulting healthcare professionals and raising public awareness against self-medication.

Ofloxacin, though commonly available, is less prescribed and sold, possibly due to factors like side effects, cost considerations, and evolving medical guidelines. Understanding local healthcare policies and ongoing research is essential to grasp antibiotic prescription dynamics.

Metronidazole is mostly prescribed but less sold, possibly due to its affordability. The paradox suggests its preference in treating prevalent infections, leading to increased prescriptions despite lower sales. Factors such as generic availability, specific medical guidelines, and local treatment protocols may contribute to its frequent prescription. Understanding the dynamics of antibiotic usage involves considering various aspects of healthcare practices and regional infection patterns.⁸

INFERENCE:

Azithromycin is mostly prescribed by doctors, it is commonly available in the medical store and it is high selling antibiotic. The preference for Azithromycin as the most prescribed and highest-selling antibiotic in a specific area could be influenced by various factors. Azithromycin is a macrolide antibiotic known for its broad-spectrum activity, convenient once-daily dosing, and effectiveness against respiratory and other infections. Its popularity may stem from factors such as patient compliance, shorter treatment durations, and suitability for specific infections.

Amoxicillin and Cefixime is a common antibiotics which is used in the treatment of common infection therefore it is commonly prescribed. Amoxicillin is indeed a commonly prescribed and widely available antibiotic. Its broad-spectrum effectiveness against various bacterial infections contributes to its popularity among healthcare professionals. The accessibility and relatively low cost of amoxicillin also make it one of the highest-selling antibiotics globally Cefixime and Amoxicillin are both commonly prescribed antibiotics with broad-spectrum activity, often used to treat various bacterial infections. While Amoxicillin belongs to the penicillin class, Cefixime is a third-generation cephalosporin. The choice between them depends on factors such as the type of infection, patient allergies, and local resistance patterns. The claim that one is the “most prescribed” or “highest selling” can vary by region and over time due to factors like healthcare practices and evolving antibiotic resistance patterns. Always follow your healthcare provider’s advice for appropriate antibiotic use. inappropriate use of antibiotics without proper medical guidance can contribute to antibiotic resistance.

Ofloxacin and Cefotaxime is less prescribed beacuse of less patients. The scenario where Ofloxacin is commonly available but less prescribed and has lower sales in Navi Mumbai might be influenced by several factors. Ofloxacin, a fluoroquinolone antibiotic, is effective against a range of bacterial infections. However, due to concerns about antibiotic resistance and potential side effects associated with fluoroquinolones, healthcare providers may prefer other antibiotics for certain conditions.^9,10,11,12

CONCLUSION:

Common antibiotics, due to their widespread need, consistently experience high demand and sales. Furthermore, second-line drugs, despite being less prevalent, demonstrate substantial sales and prescription rates, indicating their importance in specific medical contexts. This correlation emphasizes the direct connection between drug sales and the regulatory dynamics of the patient population.

To sum up, the robust demand for common antibiotics and the significant sales of second-line drugs underscore the crucial roles these medications play in addressing diverse medical needs. The direct proportionality between drug sales and the population of patients highlights the intricate interplay between healthcare requirements and pharmaceutical market dynamics. This phenomenon signifies a continuous and indispensable reliance on these drugs within the healthcare landscape. Essentially, the heightened demand and sales of common antibiotics underscore their fundamental role in addressing prevalent health issues. Concurrently, the high prescription rates

REFERENCE:

1. National Pharmaceuticals Pricing Policy, 2011 [Internet]. 2011. http://pharmaceuticals.gov.in/mshT2810/FTY2.pdf.

2. Gill J, Taylor D. Health and healthcare in India: national opportunities and global impact [Internet]. 2013. http://www.ucl.ac.uk/pharmacy/documents/news_docs/healthcareinindiajuly2013.

3. PricewaterhouseCoopers. Healthcare in India: emerging market report 2007 [Internet]. 2007. http://www.pwc.com/en_GX/gx/healthcare/pdf/emerging-market-report-hc-in-india.pdf.

4. National Commission on Macroeconomics and Health Ministry of Health & Family Welfare, Government of India. Report of the National Commission on Macroeconomics and Health [Internet]. New Delhi; 2005. http://www.who.int/macrohealth/action/Report of the National Commission.pdf.

5. Eaddy MT, Cook CL, O’Day K, et al. How patient cost-sharing trends affect adherence and outcomes: a literature review. P T [Internet]. 2012 (cited 2013 Oct 15); 37(1):45–55. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3278192&tool=pmcentrez&rendertype=abstract.

6. Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. [Internet]. 2005 (cited 2013 Oct 15); 1(3):189–99. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1661624&tool=pmcentrez&rendertype=abstract.

7. Suggs LS, Raina P, Gafni A, et al. Family physician attitudes about prescribing using a drug formulary. BMC Fam Pract. [Internet]. 2009 (cited 2013 Jul 20); 10:69. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2770461&tool=pmcentrez&rendertype=abstract.

8. Shamima K, Robert S, David S, Bruce P. Physicians’ opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern States. JMCP [Internet]. 2008; 14(8):780–9. http://www.amcp.org/data/jmcp/Oct08-all.pdf.

9. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. Hill S, editor. PLoS Med. [Internet]. Public Library of Science; 2007 (cited 2013 May 31); 4(9):e283. doi:10.1371/journal.pmed.0040283.

10. Von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ [Internet]. 2007; 335(7624): 806–8. Available from: http://www.emgo.nl/kc/Analysis/statements/observationalstudies-lancet-2007.pdf.

11. Shrank WH, Young HN, Ettner SL, et al. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. Am J Manag Care [Internet]. 2005 (cited 2013 Jul 19); 11(1): 16–22. http://www.ncbi.nlm.nih.gov/pubmed/15697096.

12. Banahan BF, Kolassa E. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med. 1997; 157: 2080–8.

Received on 11.12.2023 Modified on 01.02.2024

Asian Journal of Management. 2024;15(2):172-176.

DOI: 10.52711/2321-5763.2024.00027